Case Group AB
F:V9E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Case Group AB
F:V9E
|
SE |
|
A
|
Anglo American PLC
XMUN:NGLB
|
UK |
|
S
|
Starbucks Corp
F:SRB
|
US |
|
Credit Agricole SA
F:XCA
|
FR |
|
C
|
CVS Health Corp
SWB:CVS
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
F:75CB
|
CN |
|
G
|
General Mills Inc
XMUN:GRM
|
US |
|
I
|
Inter Pharma PCL
SET:IP
|
TH |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
US |
|
Dexus
F:0DPS
|
AU |
|
D
|
Dominion Energy Inc
DUS:DOD
|
US |
|
Inventiva SA
F:6IVA
|
FR |
|
T
|
Takkt AG
XMUN:TTK
|
DE |
Wall St Price Targets
V9E Price Targets Summary
Case Group AB
According to Wall Street analysts, the average 1-year price target for V9E is 2.6 EUR with a low forecast of 2.58 EUR and a high forecast of 2.68 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is V9E's stock price target?
Price Target
2.6
EUR
According to Wall Street analysts, the average 1-year price target for V9E is 2.6 EUR with a low forecast of 2.58 EUR and a high forecast of 2.68 EUR.
What is the Revenue forecast for Case Group AB?
Projected CAGR
-24%
Over the last 4 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 2 years is -24%.
What is the Operating Income forecast for Case Group AB?
Projected CAGR
10%
Over the last 4 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 1 year is 10%.
What is the Net Income forecast for Case Group AB?
Projected CAGR
15%
Over the last 4 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 1 year is 15%.
